Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 7 of 9 for:    klh | First posted from 01/01/2011 to 02/01/2012

Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma (ACT IV)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01480479
Recruitment Status : Completed
First Posted : November 29, 2011
Last Update Posted : January 16, 2018
Sponsor:
Information provided by (Responsible Party):
Celldex Therapeutics